Published in Medical Patent Law Weekly, February 7th, 2007
This trend article is an immediate alert from NewsRx to identify the most recent news developments at Adams Respiratory Therapeutics.
Report 1: Adams Respiratory Therapeutics, Inc., (ARxT) announced that the United States Patent and Trademark Office (USPTO) has substantially completed the first phase of the reexamination proceeding relating to one of the company's two patents covering its guaifenesin delivery system.
The USPTO patent reexamination proceeding was previously disclosed in company press releases and in public filings with the Securities...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Patent Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.